SCG Cell Therapy Pte. Ltd.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.scgcell.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Phase 1
Recruiting
- Conditions
- HCCHepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma
- Interventions
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT06617000
- Locations
- 🇨🇳
Beijing, Beijing, Beijing, China
🇨🇳Guangzhou, Guangzhou, Guangdong, China
🇨🇳Zhengzhou, Zhengzhou, Henan, China
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
Phase 1
Not yet recruiting
- Conditions
- HPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell CarcinomaHPV-Related Penile Squamous Cell CarcinomaHPV-Related Vaginal Squamous Cell CarcinomaHPV-Related Anal Squamous Cell CarcinomaHPV-Related Head and Neck Cancer
- Interventions
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT06505551
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Phase 1
Recruiting
- Conditions
- Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- SCG Cell Therapy Pte. Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT05417932
- Locations
- 🇺🇸
New York, New York, New York, United States
🇭🇰Hong Kong is., Hong Kong, Hong Kong
🇭🇰Hong Kong NT, Hong Kong, Hong Kong
News
No news found